
business
Pfizer earnings prompt calls for deal-making
Pfizer posted basically flat first-quarter earnings, prompting suggestions the largest US drugmaker needs to do deals in order to improve its growth prospects.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC